Clinical trial

Axillary Reverse Mapping Using Methylene Blue Subcutaneous Injection Can Identify Arm Lymph Nodes and Vessels, Measuring Arm Size for Lymphedema, Histopathological Examination of Arm Lymph Nodes Included With Axillary Lymph Node Dissection

NCT04137744

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-02-01

PhaseNA

Study timeline

Study start (actual)2015-02-01Date precision: month

Registry last updated2019-11-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Arm Lymphedemaunresolved

Lymphatic Spread of Breast Cancerunresolved

Early Breast Cancerunresolved

Interventions

AXILLARY REVERSE MAPPINGPROCEDURE

Sponsors & collaborators

Zagazig Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04137744 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.